1
2
3
4
5
6
7
8
9
10
11

Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases.

12
13
14
15
Extra 1

Our medicines are designed to address the severe itching and progressive liver damage of cholestatic liver diseases for children like Trey.

16
17
18

We don’t just work on behalf of patients, we work with them. We are currently recruiting patients for clinical trials.

Latest News

  • Mirum Pharmaceuticals Promotes Ian Clements to Chief Financial Officer

    January 14, 2020

  • Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat

    December 16, 2019

  • Mirum Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference

    November 25, 2019

  • Mirum Pharmaceuticals Presents Data Demonstrating Long-term Durability of Treatment Effect of Maralixibat in Children With Cholestatic Liver Diseases

    November 8, 2019

© 2020 – Mirum Pharmaceuticals